Our target trial emulation study on @BJGPOpen found that #HbA1c monitoring intervals can be individualised according to #glycaemic control in #T2DM patients, which may serve as general recommendations for T2DM patients in primary care and a practical approach to long-term management.
https://t.co/MYcTSqt9Rr
Great work by the team:
@Boyuan_WANG_hku
Dr Emily Tse
Dr Shugang Li
Hao Wu
@ChuiCeline@CindyLan897569@hkumed@HKU_FMPC@HkuPharm@CSMPR_HKUPharm
#HKU #HKUMed #FMPC #PrimaryCare #HKUPharm #CSMPR #HbA1C #TargetTrialEmulation #T2DM #Diabetes
Our latest study has been published in
@AnnalsofIM. The DOAC group had a higher 1-year risk of stroke than warfarin in Asian AF-MS patients. We also found that rivaroxaban increased the risk of stroke, while non-rivaroxaban DOACs did not.
Full paper: https://t.co/6Nq1kxVJMj
Our @AnnalsofIM paper found that #statins initiation associates with reductions of all-cause #mortality & #CVD in #T2DM adults, including low-risk groups. Results suggest statins initiation in T2DM adults even when short-term predicted CVD #risk is low.
https://t.co/SNCQlHgXVX
Our new study is out! We looked at anaemia treatments (ESAs) and fracture risk in CKD patients.
Prolonged ESA use seems linked to a higher risk of osteoporotic fractures. This suggests we need to optimise treatment to balance benefits vs. risk. Full text: https://t.co/h3GtofA46m
Happy to share our study on Pneumococcal disease epidemiology on International Journal of Infectious Diseases:
Children and adolescents had an elevated risk of gaining antimicrobial resistance, suggesting more measures to reduce S. pneumoniae infections
https://t.co/x0pvnqkL2q
Excited to share our latest study in @LancetRH_WPac : Psychotropic medication consumption increased globally after the onset of the COVID-19 pandemic, with variations in consumption patterns observed across different countries. @Esther_CSMPRHKU
https://t.co/umLRvID1Tl
Our new meta-analysis in Hypertension Research confirms Sacubitril/Valsartan effectively reduces both office and out-of-office blood pressure.
This was a fantastic international collaboration with our colleagues at Chulalongkorn University.
https://t.co/gzOjOurHA4
Our multinational database study in @eClinicalMed
compared antihypertensive prescribing trends in Hong Kong, United Kingdom, Sweden, and Australia, providing evidence on the use of blood pressure-lowering drugs before and after a diagnosis of dementia.
https://t.co/CDKZL0dcQq
Excited to share our new publication on using DCE and C-TTO to value population mental well-being in Hong Kong. We identified key task features, cultural interpretations, and decision strategies. Thanks to HKU team, and Oxford and Warwick collaborators!
https://t.co/y6I2e0c9Q4
Antiseizure medications consumption in 73 countries and regions from 2... https://t.co/HNXH8GE6d2
Our Aston U, HKU, UCL, WHO study shows that inequities in access to newer antiseizure drugs in developing countries where valproate used a lot. Good risk management is needed
Excited to share our latest study in @TheLancet: long-acting injectable antipsychotics (LAIAs) are more effective than oral and equally safe for older people, except for higher risk of EPS with typical LAIAs, but not with atypical LAIAs. @Esther_CSMPRHKU
https://t.co/xQB0YitlVz
Our @CMAJ study found a less stringent #risk threshold of 30% for intensifying #PrimaryCare encounters frequency is associated with increased overall #CVD risks and all-cause #mortality of aged 60+ #T2DM patients, but not for those below 60.
https://t.co/zNwz2HTKNd
Our age-specific models accurately predicted the post-acute #mortality risk within 1 year of #COVID infection, optimizing clinical strategies and resource allocation in global burden of #LongCOVID management. Published on @_qjm_.
https://t.co/KypBNSfUyJ
Our modified self-controlled case series (https://t.co/ovfmS22Lul) did not identify an increased #ischemic_stroke risk with #PPI_monotherapy. However, co-prescription with #antithrombotics was associated with a higher risk. Careful monitoring is needed for them.
@ChuiCeline
First paper published by Meta Superintelligence Labs!
In this paper, they make RAG faster by swapping most retrieved tokens for precomputed & reusable chunk embeddings, called REFRAG
This method improves its speed by 30x and fitting 16x longer contexts without accuracy loss
Our simulation model supports the cost-effectiveness of PSA screening in China. Personalised screening based on genetic risk may provide an efficient alternative to uniform strategies by reducing unnecessary interventions for lower risk individual.https://t.co/RmgT9apD7k
Our @JACCJournals paper found that #statin use for primary #prevention was associated in all-cause #mortality and major #CVD reductions with a very low risk of adverse effects among #T1DM adults, guiding personalized statin #treatment decisions in T1DM.
https://t.co/oRKFeT0DvQ
Our paper found #specialist outpatient clinic (#SOPC) service disruption like #COVID was associated with increased risk of #mortality and #CVD among #DM patients. Findings support #primarycare clinics are essential in public health crises.
https://t.co/1MGRoaO0th